Sagoo G, Butterworth A, Sanderson S, Shaw-Smith C, Higgins J, Burton H. Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects. Genetics in Medicine. 2009 Mar;11(3): 139-46

Melzer D, Hogarth S, Liddell K, Ling T, Sanderson S, Zimmern R. Genetic tests for common diseases: new insights, old concerns. British Medical Journal. 2008 Mar 15;336(7644):590-3

Sanderson S. Joint effects of NAT1, NAT2 genes and smoking on bladder carcinogenesis: a HuGE literature-based systematic review and evidence synthesis. American Journal of Epidemiology. 2006

Green A, Burton H, Preece M, Sanderson S. The frequency of inherited metabolic disorders in the West Midlands, United Kingdom. Archives of Disease in Childhood. 2006

Shortland G, Burton H, Sanderson S, Lee P. Needs assessment and review of services for people with inherited metabolic disease in the United Kingdom. Journal of Inherited Metabolic Disease. 2006

Sagoo G, Subramonia-Iyer S, Sanderson S, Higgins J, Burton H, Brice P. Array-based comparative genomic hybridisation for investigating chromosomal abnormalities in patients with learning disability: meta-analysis of diagnostic and false positive yields. Genetics In Medicine. 2006

Sanderson S, Emery J, Higgins J. CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: A HuGEnet trade mark systematic review and meta-analysis. Genetics In Medicine. 2005;7(2):97-104

Higgins J, Sanderson S, Zimmern R, Kroese M, Patch C, Emery J. How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom. Genetics in Medicine. 2005;7(7):495-500